Equities

China Health Group Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

China Health Group Inc

Actions
  • Price (HKD)0.14
  • Today's Change0.00 / 0.00%
  • Shares traded220.00k
  • 1 Year change-20.00%
  • Beta0.1249
Data delayed at least 15 minutes, as of Feb 13 2026 03:11 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

China Health Group Inc is an investment holding company primarily engaged in the provision of post-marketing research and academic extension services. The Company's services include hospital big data clinical research, digital research product promotion services, jointly build digital research and development clinical research specialties, specialized medical and pharmaceutical services,special specialty medical drug clinic, rehabilitation medical and travel medical services. The Company's business mainly covers the fields of mental health and psychological well-being, neuroscience and chronic disease management, and allergy and respiratory diseases.

  • Revenue in HKD (TTM)33.69m
  • Net income in HKD-14.90m
  • Incorporated2002
  • Employees44.00
  • Location
    China Health Group IncBlock 17Jianwai SOHO, Chaoyang DistrictBEIJING 100089ChinaCHN
  • Websitehttp://www.chgi.net
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
PhoenixBio Co Ltd81.39m-10.43m102.53m69.00--1.33--1.26-52.37-52.37396.00372.680.67970.84118.0723,170,680.00-8.71-4.25-10.53-5.5778.4467.17-12.82-7.193.40--0.1831---10.143.29-1,801.92--1.08--
IDT Australia Ltd109.77m-44.57m111.03m156.00--0.9227--1.01-0.0189-0.01890.04650.05090.58172.602.59---23.61-13.43-29.19-16.0669.1979.42-40.60-30.012.36-9.620.3222--40.656.99-48.96--11.30--
Noxopharm Ltd15.64m-27.00m117.91m1.00k--30.92--7.54-0.0167-0.01670.00970.00240.4979--1.06---85.95-49.70-156.33-59.16-----172.63-229.01----0.7823--17.54-19.45-36.50------
BTC Health Ltd55.05k22.01m138.30m1.006.012.496.282,512.230.01170.01170.000030.02820.0014------54.89-13.7156.47-14.66----39,972.79-3,966.34----0.00---39.12-43.28277.27------
China Health Group Inc33.69m-14.90m139.35m44.00--1.56--4.14-0.015-0.0150.03390.08990.2495--0.4284802,180.70-11.041.10-15.391.4940.3968.02-44.233.70----0.000.0023.47-15.9975.06--345.81--
Kringle Pharma Inc3.70m-46.10m141.05m17.00--2.21--38.15-130.95-130.9510.48170.570.032--1.014,272,000.00-39.93-23.52-42.03-24.93-----1,246.73-349.8916.65-3,738.200.00---9.77-31.17-21.13------
Holista Colltech Limited32.23m3.23m156.55m3.0035.00--43.804.860.00220.00230.0195-0.00161.763.835.84--17.53-46.13---85.4049.6655.159.98-38.850.37823.93-----5.82-5.0797.92---37.01--
Veritas In Silico Inc4.64m-21.67m160.84m19.00--1.77--34.66-65.62-65.6214.05274.990.0441--6.11---20.59---21.32-------467.05--18.35-------53.18---80.03------
NPT Co Ltd0.00-13.57m173.58m7.00--43.82-----54.98-54.980.0015.980.00----0.00-318.44---439.04-------------2,152.880.00-------68.67------
Data as of Feb 13 2026. Currency figures normalised to China Health Group Inc's reporting currency: Hong Kong Dollar HKD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.